ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,446Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 118

$1.37M Total Retail Price of All Prescriptions

Rank: 4 out of 118

552 Patients Receiving at Least One Drug in Part D
47%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 552 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

13% of this provider’s 552 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 9,889 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 59%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $175 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
AMLODIPINE BESYLATE 583 432 1 12
CRESTOR 458 322 2 29
MELOXICAM 458 338 2 38
OMEPRAZOLE 451 263 4 7
METOPROLOL SUCCINATE 430 296 5 24
ADVAIR DISKUS 425 165 6 2
LISINOPRIL 421 231 7 20
ZOLPIDEM TARTRATE 380 190 8 18
FUROSEMIDE 377 207 9 9
METFORMIN HCL 368 237 10 25
SIMVASTATIN 319 188 11 14
SPIRIVA 312 129 12 1
LEVOTHYROXINE SODIUM 270 166 13 15
PROAIR HFA 261 67 14 4
LOSARTAN POTASSIUM 259 195 15 28
ATORVASTATIN CALCIUM 234 156 16 22
NEXIUM 229 170 17 49
PLAVIX 219 159 18 64
CLOPIDOGREL 208 155 19 46
METOPROLOL TARTRATE 195 126 20 17
JANUVIA 188 157 21 68
LYRICA 174 80 22 71
POTASSIUM CHLORIDE 172 84 23 23
NAPROXEN 169 77 24 73
DILTIAZEM ER 167 74 25 74
DIOVAN 162 102 26 47
HYDROCHLOROTHIAZIDE 159 70 27 34
OXYCODONE-ACETAMINOPHEN 154 29 S2 28 77
SINGULAIR 151 62 29 10
ALLOPURINOL 149 60 30 53
DILTIAZEM 24HR ER 146 70 31 65
TRAMADOL HCL 145 82 32 44
CELEBREX 143 87 33 80
TAMSULOSIN HCL 142 102 34 51
PREDNISONE 134 33 35 3
IBUPROFEN 134 68 35 84
EXFORGE 131 100 37 85
FLUOXETINE HCL 131 53 37 36
CARVEDILOL 125 84 39 60
VENTOLIN HFA 125 35 39 8
ZETIA 124 66 41 54
ACETAMINOPHEN-CODEINE 123 92 S3 42 88
LANTUS SOLOSTAR 112 41 43 91
WARFARIN SODIUM 111 37 44 16
FLUTICASONE PROPIONATE 101 40 45 13
GABAPENTIN 97 58 46 34
LOVASTATIN 94 62 47 94
HYDRALAZINE HCL 92 72 48 95
DEXILANT 91 79 49 96
BYSTOLIC 90 23 50 63
LIPITOR 90 78 50 55
CIPROFLOXACIN HCL 90 40 50 97
EXFORGE HCT 88 51 53 99
AVODART 88 73 53 99
ALENDRONATE SODIUM 86 71 55 45
LIDODERM 85 76 56 101
LIDOCAINE 84 49 57 104
TOPROL XL 80 76 58 107
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 51 59 108
ATENOLOL 79 58 59 57
SERTRALINE HCL 77 48 61 41
PAROXETINE HCL 76 57 62 79
MICARDIS 74 74 63 109
ACTOS 74 50 63 109
COMBIVENT 73 20 65 11
CYCLOBENZAPRINE HCL 72 0 R 66 112
DILTIAZEM 24HR CD 72 37 66 112
AZITHROMYCIN 71 31 68 6
LOSARTAN-HYDROCHLOROTHIAZIDE 70 31 69 115
CLONIDINE HCL 65 29 70 119
PANTOPRAZOLE SODIUM 65 26 70 83
MONTELUKAST SODIUM 65 20 70 21
AMOX TR-POTASSIUM CLAVULANATE 65 18 70 69
TAZTIA XT 65 29 70 119
VYTORIN 64 49 75 88
CARTIA XT 63 29 76 121
OXYCODONE HCL 62 16 S2 77 128
TRICOR 61 44 78 129
SYMBICORT 58 37 79 5
NIASPAN 53 23 80 81
METFORMIN HCL ER 52 33 81 140
DIOVAN HCT 52 42 81 140
MICARDIS HCT 50 39 83 144
LACTULOSE 50 32 83 144
ESCITALOPRAM OXALATE 50 24 83 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.